Anti-Kairi Virus (KRIV) Nucleocapsid ant - 0.2mg/mL
Rif. 3D-CRB2005080
| 20µg | 266,00 € | ||
| 100µg | 479,00 € |
Informazioni sul prodotto
KRIV belongs to the Peribunyaviridae family of viruses (previously called Bunyaviridae). KRIV was first isolated from mosquito species in Trinidad including Aedes, Wyeomia, Culex and Psorophora spp. and has since been isolated from mosquitoes and vertebrates in Central and South America. Although between 6-18% of humans and up to 48% of horses have antibodies to KRIV, it does not cause any documented clinical disease symptoms in humans or animals. KRVI consists of three genome segments (called L [large], M [medium] and S [small]) which are encapsidated by the nucleocapsid (N) protein. These segments associate with the viral RNA-dependent RNA polymerase, the L protein, to form ribonucleoprotein complexes (RNP) termed nucleocapsids. RNPs are contained within a lipid envelope also containing the viral glycoproteins, Gn and Gc.
1mg/ml. For use in WB and ELISA. Reacts with Kairi Virus.
Image: Western blot analysis of BHK-21 cells infected with the Kairi virus.
Proprietà chimiche
Richiesta tecnica su: 3D-CRB2005080 Anti-Kairi Virus (KRIV) Nucleocapsid ant - 0.2mg/mL
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
